|

Lanalidomide with Zn-DDC Clinical Trials

1 actively recruiting trial

Top Sponsors

  • The Royal Wolverhampton Hospitals NHS Trust1

Indications

  • Multiple Myeloma1
  • Cancer1

Other1 trial

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.